Wikisage, the free encyclopedia of the second generation, is digital heritage
Gabapentine: Difference between revisions
Jump to navigation
Jump to search
({{refs}}) |
No edit summary |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
gabapentin -gabapentinoid (see also pregabalin)- is an anticonvulsant agent | gabapentin -gabapentinoid (see also pregabalin)- is an anticonvulsant agent | ||
and off label for the treatment of alcohol dependence<ref>http://ns.amcp.org/data/jmcp/Contemporary%20Subject-559-568.pdf Examination of the Evidence for Off-Label Use of Gabapentin</ref> | and off label for the treatment of alcohol dependence<ref>[http://ns.amcp.org/data/jmcp/Contemporary%20Subject-559-568.pdf Examination of the Evidence for Off-Label Use of Gabapentin]</ref> | ||
Hallucinations as abuse substance has been reported, and fatalities has been reported in concomitant use with opioids | Hallucinations as abuse substance has been reported, and fatalities has been reported in concomitant use with opioids | ||
==ATC== | ==ATC== | ||
<gallery>File:Gabapentin_3D.png</gallery> | |||
{| style="background:Ivory; color:black" border=1 cellspacing=1 cellpadding=5 | {| style="background:Ivory; color:black" border=1 cellspacing=1 cellpadding=5 | ||
|colspan=2| <center> | |colspan=2| <center> | ||
| Line 12: | Line 12: | ||
|} | |} | ||
==Weblinks== | |||
*[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926640/pdf/CEJU-71-1574.pdf Efficacy of sertraline and gabapentin in the treatment of urethral pain syndrome: retrospective results of a single institutional cohort] | *[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926640/pdf/CEJU-71-1574.pdf Efficacy of sertraline and gabapentin in the treatment of urethral pain syndrome: retrospective results of a single institutional cohort] | ||
*[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5924409/ Abuse of Prescription Drugs in the Context of Novel Psychoactive Substances (NPS): A Systematic Review] | *[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5924409/ Abuse of Prescription Drugs in the Context of Novel Psychoactive Substances (NPS): A Systematic Review] | ||
| Line 20: | Line 19: | ||
*[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5817358/ Reversible Thrombocytopenia after Gabapentin in an HIV-Positive Patient] | *[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5817358/ Reversible Thrombocytopenia after Gabapentin in an HIV-Positive Patient] | ||
*[https://www.wecowi.de/index.php?title=Gabapentin&oldid=207124 | *<nowiki>[https://www.wecowi.de/index.php?title=Gabapentin&oldid=207124]</nowiki> | ||
{{refs}} | {{refs}} | ||
[[Category:Anticonvulsants]] | |||
Latest revision as of 15:02, 21 May 2019
gabapentin -gabapentinoid (see also pregabalin)- is an anticonvulsant agent and off label for the treatment of alcohol dependence[1]
Hallucinations as abuse substance has been reported, and fatalities has been reported in concomitant use with opioids
ATC
Weblinks
- Efficacy of sertraline and gabapentin in the treatment of urethral pain syndrome: retrospective results of a single institutional cohort
- Abuse of Prescription Drugs in the Context of Novel Psychoactive Substances (NPS): A Systematic Review
- Gabapentin dose and the 30-day risk of altered mental status in older adults: A retrospective population-based study
- Reversible Thrombocytopenia after Gabapentin in an HIV-Positive Patient
- [https://www.wecowi.de/index.php?title=Gabapentin&oldid=207124]
| References: |